two new pending drugs for diabetes, Pargluva (muraglitazar) and Exubera (inhaled insulin)

September 2005

You'll hear about two new pending drugs for diabetes, Pargluva (muraglitazar) and Exubera (inhaled insulin).

Pargluva will be first in a new class of oral drugs...called glitazars.

Glitazars are called "two-in-one" drugs. They improve blood glucose like a glitazone AND improve lipids like a fibrate.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote